Back to ROIV
VANGUARD GROUP INC ROIV Position History
Roivant Sciences Ltd. • Healthcare
Quarters held
20
Latest value
$7.2M
Q4 2025
Peak value
$841.4M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $405.1M |
| Q1 2025 | $570K |
| Q1 2025 | $858K |
| Q1 2025 | $1.6M |
| Q1 2025 | $3.2M |
| Q2 2025 | $436.2M |
| Q2 2025 | $540K |
| Q2 2025 | $910K |
| Q2 2025 | $2M |
| Q2 2025 | $3.5M |
| Q3 2025 | $1.2M |
| Q3 2025 | $2.6M |
| Q3 2025 | $37.3M |
| Q3 2025 | $5M |
| Q3 2025 | $541M |
| Q4 2025 | $841.4M |
| Q4 2025 | $58M |
| Q4 2025 | $2M |
| Q4 2025 | $4.1M |
| Q4 2025 | $7.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q4 2025 | $7.2M | 333.0K | — | — |
| Q4 2025 | $4.1M | 188.5K | — | — |
| Q4 2025 | $2M | 92.1K | — | — |
| Q4 2025 | $58M | 2.67M | — | — |
| Q4 2025 | $841.4M | 38.77M | — | — |
| Q3 2025 | $541M | 35.75M | — | — |
| Q3 2025 | $5M | 331.9K | — | — |
| Q3 2025 | $37.3M | 2.46M | — | — |
| Q3 2025 | $2.6M | 172.8K | — | — |
| Q3 2025 | $1.2M | 80.8K | — | — |
| Q2 2025 | $3.5M | 311.7K | — | — |
| Q2 2025 | $2M | 178.7K | — | — |
| Q2 2025 | $910K | 80.8K | — | — |
| Q2 2025 | $540K | 47.9K | — | — |
| Q2 2025 | $436.2M | 38.71M | — | — |
| Q1 2025 | $3.2M | 313.6K | — | — |
| Q1 2025 | $1.6M | 158.9K | — | — |
| Q1 2025 | $858K | 85.0K | — | — |
| Q1 2025 | $570K | 56.5K | — | — |
| Q1 2025 | $405.1M | 40.15M | — | — |
Other funds holding ROIV
$1.2B
$1.2B
$857.7M
$758.4M
$731.1M